These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 36883644)

  • 1. Microglial activation in the frontal cortex predicts cognitive decline in frontotemporal dementia.
    Malpetti M; Cope TE; Street D; Jones PS; Hezemans FH; Mak E; Tsvetanov KA; Rittman T; Bevan-Jones WR; Patterson K; Passamonti L; Fryer TD; Hong YT; Aigbirhio FI; O'Brien JT; Rowe JB
    Brain; 2023 Aug; 146(8):3221-3231. PubMed ID: 36883644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglial activation and tau burden predict cognitive decline in Alzheimer's disease.
    Malpetti M; Kievit RA; Passamonti L; Jones PS; Tsvetanov KA; Rittman T; Mak E; Nicastro N; Bevan-Jones WR; Su L; Hong YT; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Brain; 2020 May; 143(5):1588-1602. PubMed ID: 32380523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study.
    Whitwell JL; Przybelski SA; Weigand SD; Ivnik RJ; Vemuri P; Gunter JL; Senjem ML; Shiung MM; Boeve BF; Knopman DS; Parisi JE; Dickson DW; Petersen RC; Jack CR; Josephs KA
    Brain; 2009 Nov; 132(Pt 11):2932-46. PubMed ID: 19762452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum.
    Bevan-Jones WR; Cope TE; Jones PS; Kaalund SS; Passamonti L; Allinson K; Green O; Hong YT; Fryer TD; Arnold R; Coles JP; Aigbirhio FI; Larner AJ; Patterson K; O'Brien JT; Rowe JB
    Brain; 2020 Mar; 143(3):1010-1026. PubMed ID: 32179883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthy brain connectivity predicts atrophy progression in non-fluent variant of primary progressive aphasia.
    Mandelli ML; Vilaplana E; Brown JA; Hubbard HI; Binney RJ; Attygalle S; Santos-Santos MA; Miller ZA; Pakvasa M; Henry ML; Rosen HJ; Henry RG; Rabinovici GD; Miller BL; Seeley WW; Gorno-Tempini ML
    Brain; 2016 Oct; 139(Pt 10):2778-2791. PubMed ID: 27497488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right temporal degeneration and socioemotional semantics: semantic behavioural variant frontotemporal dementia.
    Younes K; Borghesani V; Montembeault M; Spina S; Mandelli ML; Welch AE; Weis E; Callahan P; Elahi FM; Hua AY; Perry DC; Karydas A; Geschwind D; Huang E; Grinberg LT; Kramer JH; Boxer AL; Rabinovici GD; Rosen HJ; Seeley WW; Miller ZA; Miller BL; Sturm VE; Rankin KP; Gorno-Tempini ML
    Brain; 2022 Nov; 145(11):4080-4096. PubMed ID: 35731122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal structural and molecular neuroimaging in agrammatic primary progressive aphasia.
    Tetzloff KA; Duffy JR; Clark HM; Strand EA; Machulda MM; Schwarz CG; Senjem ML; Reid RI; Spychalla AJ; Tosakulwong N; Lowe VJ; Jack CR; Josephs KA; Whitwell JL
    Brain; 2018 Jan; 141(1):302-317. PubMed ID: 29228180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neural substrates of transdiagnostic cognitive-linguistic heterogeneity in primary progressive aphasia.
    Ramanan S; Halai AD; Garcia-Penton L; Perry AG; Patel N; Peterson KA; Ingram RU; Storey I; Cappa SF; Catricala E; Patterson K; Rowe JB; Garrard P; Ralph MAL
    Alzheimers Res Ther; 2023 Dec; 15(1):219. PubMed ID: 38102724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping behavioural, cognitive and affective transdiagnostic dimensions in frontotemporal dementia.
    Ramanan S; El-Omar H; Roquet D; Ahmed RM; Hodges JR; Piguet O; Lambon Ralph MA; Irish M
    Brain Commun; 2023; 5(1):fcac344. PubMed ID: 36687395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-awareness in neurodegenerative disease relies on neural structures mediating reward-driven attention.
    Shany-Ur T; Lin N; Rosen HJ; Sollberger M; Miller BL; Rankin KP
    Brain; 2014 Aug; 137(Pt 8):2368-81. PubMed ID: 24951639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal multimodal imaging and clinical endpoints for frontotemporal dementia clinical trials.
    Staffaroni AM; Ljubenkov PA; Kornak J; Cobigo Y; Datta S; Marx G; Walters SM; Chiang K; Olney N; Elahi FM; Knopman DS; Dickerson BC; Boeve BF; Gorno-Tempini ML; Spina S; Grinberg LT; Seeley WW; Miller BL; Kramer JH; Boxer AL; Rosen HJ
    Brain; 2019 Feb; 142(2):443-459. PubMed ID: 30698757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study.
    Premi E; Grassi M; van Swieten J; Galimberti D; Graff C; Masellis M; Tartaglia C; Tagliavini F; Rowe JB; Laforce R; Finger E; Frisoni GB; de Mendonça A; Sorbi S; Gazzina S; Cosseddu M; Archetti S; Gasparotti R; Manes M; Alberici A; Cardoso MJ; Bocchetta M; Cash DM; Ourselin S; Padovani A; Rohrer JD; Borroni B;
    Brain; 2017 Jun; 140(6):1784-1791. PubMed ID: 28460069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting functional decline in behavioural variant frontotemporal dementia.
    Josephs KA; Whitwell JL; Weigand SD; Senjem ML; Boeve BF; Knopman DS; Smith GE; Ivnik RJ; Jack CR; Petersen RC
    Brain; 2011 Feb; 134(Pt 2):432-48. PubMed ID: 21252111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of microglial activation with white matter changes in dementia with Lewy bodies.
    Nicastro N; Mak E; Williams GB; Surendranathan A; Bevan-Jones WR; Passamonti L; Vàzquez Rodrìguez P; Su L; Arnold R; Fryer TD; Hong YT; Aigbirhio FI; Rowe JB; O'Brien JT
    Neuroimage Clin; 2020; 25():102200. PubMed ID: 32032816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synaptic Loss in Frontotemporal Dementia Revealed by [
    Malpetti M; Jones PS; Cope TE; Holland N; Naessens M; Rouse MA; Rittman T; Savulich G; Whiteside DJ; Street D; Fryer TD; Hong YT; Milicevic Sephton S; Aigbirhio FI; O Brien JT; Rowe JB
    Ann Neurol; 2023 Jan; 93(1):142-154. PubMed ID: 36321699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two insular regions are differentially involved in behavioral variant FTD and nonfluent/agrammatic variant PPA.
    Mandelli ML; Vitali P; Santos M; Henry M; Gola K; Rosenberg L; Dronkers N; Miller B; Seeley WW; Gorno-Tempini ML
    Cortex; 2016 Jan; 74():149-57. PubMed ID: 26673947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroinflammation is highest in areas of disease progression in semantic dementia.
    Pascual B; Funk Q; Zanotti-Fregonara P; Cykowski MD; Veronese M; Rockers E; Bradbury K; Yu M; Nakawah MO; Román GC; Schulz PE; Arumanayagam AS; Beers D; Faridar A; Fujita M; Appel SH; Masdeu JC
    Brain; 2021 Jun; 144(5):1565-1575. PubMed ID: 33824991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early microglial activation and peripheral inflammation in dementia with Lewy bodies.
    Surendranathan A; Su L; Mak E; Passamonti L; Hong YT; Arnold R; Vázquez Rodríguez P; Bevan-Jones WR; Brain SAE; Fryer TD; Aigbirhio FI; Rowe JB; O'Brien JT
    Brain; 2018 Dec; 141(12):3415-3427. PubMed ID: 30403785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.